Upon TLR2 ligand stimulation, the mRNA expression of CCL5, CCL8, CCL13, CCL18, and CCL22 from AD groups were significantly higher than those from healthy controls (Figures 2(b)–2(d), 2(f), and 2(g)). This evidence concerns the gene CCL18 and Alzheimer disease.